Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions for the pharmaceutical, biotechnology and life sciences industries.
We deliver an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug lifecycle, from development to commercial stages.
Our core capabilities in scientific research and development (R&D), commitment to technical innovation and engineering excellence are central to our ability to offer value-added solutions to clients.
Containment and delivery solutions for pharmaceutical applications
With more than 70 years’ experience in producing advanced glass containers for the biopharmaceutical industry, Stevanato Group offers drug containment solutions, plastic solutions and drug delivery systems.
We provide a range of products tailored to specific biopharmaceutical requirements and can also offer support for plastic products.
Our experts are specialists in multi-component injection moulding and automated system assembly. As a one-stop solution provider and manufacturer, we can cover all parts of the product development process, packaging and sterilising as needed.
We combine our knowledge to offer integrated solutions, from early development to launched combination products. Our core and extended drug delivery systems teams will work closely with your staff and consulting experts to help you successfully market your drug product in a device that suits your patients’ needs.
Technology and equipment for healthcare product manufacturing
Stevanato Group provides three pillars of technologies and manufacturing, namely visual inspection, assembly equipment and secondary packaging.
Using our wide portfolio and extensive inspection expertise, we deliver flexible assessment solutions at all stages of the product lifecycle, from the laboratory to high-volume production, for a broad range of applications.
We design, develop and manufacture high-yield assembly lines for medical devices such as auto-injectors, pen injectors and inhalers, to develop customised solutions. A focus on robotics, quick-format change and gentle handling ensure highly reliable and efficient production.
Stevanato Group can also provide secondary packaging lines that can be adapted to different volumes for multiple product formats, including primary glass containers and drug delivery devices.
Analytical and testing services for packaging materials
As part of Stevanato Group’s commitment to R&D, our analytical testing facilities focus on investigating the physico-chemical properties of primary packaging materials and components, as well as studying the interactions between container closure systems and drugs.
We rely on a multi-disciplinary team of highly skilled professionals, including scientists, engineers, pharmaceutical chemists and biotechnologists. Their knowledge and experience cover a range of specialised areas, from container closure systems to drug delivery devices.
About Stevanato Group
Founded in 1949, Stevanato Group’s aim is to make a difference in the pharmaceutical and healthcare industries.
We have a presence in nine countries and operate nine plants for pharmaceutical and healthcare products, five plants for high–quality technologies, and two sites for analytical services.
